• 1
    Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. The incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999; 33: 829839.
  • 2
    Hricik DE. Steroid-free immunosuppression in kidney transplantation: An editorial review. Am J Transplant 2002; 2: 1924.
  • 3
    Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002; 2: 807818.
  • 4
    Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 1993; 4: 13001305.
  • 5
    Vincenti F. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients. Transpl Int 2004; 17: 395401.
  • 6
    Meier-Kriesche H-U. Mycophenolate mofetil-based immunosuppressive minimization and withdrawal strategies in renal transplantation: Possible risks and benefits. Curr Opin Nephrol Hypertens 2006; 15(Suppl 1): S1S5.
  • 7
    Kandaswamy R, Melancon JK, Dunn T et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients—an interim analysis. Am J Transplant 2005; 5: 15291536.
  • 8
    Kaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction—long-term results. Am J Transplant 2005; 5: 25392548.
  • 9
    Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporin microemulsion and mycophenolate mofetil. Am J Transplant 2003; 3: 306311.
  • 10
    Rostaing L, Cantarovich D, Mourad G et al. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 2005; 79: 807814.
  • 11
    Kumar MS, Xiao SG, Fyfe B et al. Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies. Clin Transplant 2005; 19: 6169.
  • 12
    ter Meulen CG, van Riemsdijk I, Hené RJ et al. Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor α therapy: A prospective, randomized, multicenter study. Am J Transplant 2004; 4: 803810.
  • 13
    Cole E, Landsberg D, Russell D et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001; 72: 845850.
  • 14
    Birkeland SA. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Transplantation 1998; 66: 12071210.
  • 15
    Nankivell BJ, Gruenewald SM, Allen R, Chapman JR. Predicting glomerular filtration rate after kidney transplantation. Transplantation 1995; 59: 16831689.
  • 16
    Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713723.
  • 17
    Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study. The Rapamune US Study Group. Lancet 2000; 356: 194202.
  • 18
    Meier-Kriesche H-U, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378383.
  • 19
    Hricik DE. Steroid-free immunosuppression in kidney transplantation: An editorial review. Am J Transplant 2002; 2: 1924.
  • 20
    Muratore A, Ribero D, Ferrero A, Bergero R, Capussotti L. Prospective randomized study of steroids in the prevention of ischemic injury during hepatic resection with pedicle clamping. Br J Surg 2003; 90: 1722.
  • 21
    Roozrokh HC, Chen L, Scandling JD, Momsen A, Tan J, Busque S. Effect of steroid avoidance on early graft function after kidney transplantation. Am J Transplant 2004; 4(Suppl 8); 354.
  • 22
    Woodle ES, Astellas Steroid Withdrawal Group. A randomized double-blind, placebo-controlled trial of early corticosteroid cessation versus chronic corticosteroids: Four year results. Am J Transplant 2007; 7(Suppl 2): 1704 (Abstract).